Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice
Authors
Keywords
-
Journal
GROWTH FACTORS
Volume 33, Issue 5-6, Pages 419-429
Publisher
Informa UK Limited
Online
2016-01-05
DOI
10.3109/08977194.2015.1125349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoglycemic action of vitamin K1 protects against early-onset diabetic nephropathy in streptozotocin-induced rats
- (2015) M.K.N. Sai Varsha et al. NUTRITION
- Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells
- (2014) Mariola Dorecka et al. Pharmacological Reports
- Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes
- (2013) Ryo Kodera et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Renal Cortical Lactate Dehydrogenase: A Useful, Accurate, Quantitative Marker of In Vivo Tubular Injury and Acute Renal Failure
- (2013) Richard A. Zager et al. PLoS One
- Microinflammation in the pathogenesis of diabetic nephropathy
- (2013) Kenichi Shikata et al. Journal of Diabetes Investigation
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
- (2012) Hari Hendarto et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Histological and functional renal alterations caused by Bothrops alternatus snake venom: Expression and activity of Na+/K+-ATPase
- (2011) Alessandra Linardi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Molecular bandages: inside-out, outside-in repair of cellular membranes. Focus on “Myoferlin is critical for endocytosis in endothelial cells”
- (2009) Stephanie Cipta et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas
- (2009) Selda Gezginci-Oktayoglu et al. Biochemistry and Cell Biology
- Therapeutic Strategies in the Treatment of Diabetic Nephropathy - a Translational Medicine Approach
- (2009) Imtiaz Shah et al. CURRENT MEDICINAL CHEMISTRY
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
- (2009) Rania Abu-Hamdah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney - another reason for diabetic nephropathy?
- (2008) Andrea Fekete et al. JOURNAL OF PHYSIOLOGY-LONDON
- The Role of chemokines and chemokine receptors in diabetic nephropathy
- (2007) Christiane Ruster Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started